Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Western Resources Corp. Provides Bi-weekly MCTO Status Update
-
RBC iShares Expands Access to BlackRock’s Bitcoin ETP Platform
-
Mandalay Resources Delivers Strong Q4 Gold and Antimony Performance, Achieves Top End of 2024 Production Guidance Leading to $76 Million Cash Balance
-
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
-
Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
-
URBN Reports Record Holiday Sales
-
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
-
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
-
Arbutus Provides 2025 Corporate and Financial Update
-
Lower Colorado River Authority Widens Wireless Communications Capabilities with Additional Spectrum Licenses from Anterix
-
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
-
MNP Consumer Debt Index Plunges to 79 Points, the Second-Lowest Level Ever Recorded (-10pts)
-
Alliance Witan PLC - Net Asset Value
-
Form 8.3 - [ALLIANCE PHARMA PLC - Opening Disclosure - 10 01 2025] - (CGAML)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 10 01 2025] - (CGWL)
-
EDIBLE GARDEN Signs Non-Binding Letter of Intent to Acquire NARAYAN GROUP to Expand into the European and North American Markets
-
Flow Capital Appoints Brian Beattie to its Board of Directors
-
Form 8.3 - [LOUNGERS PLC - 10 01 2025] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 10 01 2025] - (CGWL)
-
Patent and Trademark Office Issues Ensemble’s Latest Patent – Using AI to Improve Clinician and Patient Experience
-
Option Care Health Announces Preliminary Financial Results for Fourth Quarter and Full Year 2024 and Preliminary Financial Expectations for Full Year 2025
-
Gilat Receives Over $3 Million in Orders to Support LEO Constellations
-
EnviroGold Global Closes Upsized Strategic Unit Offering to Raise $4.1 Million and Announces Appointment of New Director
-
Next Hydrogen Announces Director Resignation
-
Aura Completes the Acquisition of Bluestone
-
Black Diamond Group Limited Launches Automatic Share Purchase Program
-
A Promising First Year for the MTY Group Foundation/Fondation Groupe MTY
-
ISC Reports Solid Start to 2028 Growth Goal in 2024 and Provides Management Update
-
ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors
-
Skye Bioscience Provides 2025 Look Ahead and Year in Review
-
Noodles & Company Announces Preliminary Revenue Results for the Fourth Quarter of 2024
-
Potbelly Corporation Reports Preliminary Results for Fourth Fiscal Quarter of 2024
-
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones
-
Zumiez Inc. Reports Holiday 2024 Sales Results
-
BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million
-
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2024
-
Cartesian Therapeutics Highlights Progress and 2025 Strategic Priorities Across Pipeline of mRNA Cell Therapies for Autoimmune Diseases
-
Chimerix to Speak Today at The White House Cancer Moonshot Forum
-
Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2024
-
Nevada Lithium to Participate in the “2025 Mining Conference: Mining and Supplying Critical Minerals & Precious Metals”
-
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
-
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio
-
Microbix & API Ensuring Flu Tests Can Detect H5N1 Strain
-
Fusion Fuel Closes on $1.28 Million Senior Convertible Notes and $25 Million Equity Line of Credit
-
Nurix Therapeutics Outlines 2025 Goals and Objectives for Advancement of Its Robust Pipeline in Cancer and Autoimmune Diseases
-
Abercrombie & Fitch Co. Increases Fourth Quarter and Full Year Net Sales Outlook on Better-Than-Expected Holiday Sales
-
EyePoint Provides Company Update and Anticipated Development Milestones for 2025
-
Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results
-
Stingray to Release its Financial Results for the Third Quarter of Fiscal 2025
-
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities at the 43rd Annual J.P. Morgan Healthcare Conference
